This is a limited company view. Sign up for a Free Trial to see everything.

A new approach to coronary stenting, Svelte IDS and RX technologies reduce the steps, time, cost of procedures, and enhance patient outcomes. Learn more.

B2B
B2C
Biotechnology
Healthcare
Medical Devices
Pharmaceuticals

Overview

Location

New York

Founded

2007

Employees

22

Stage

Late

Total funding

$68M

Last funding

3 years ago

Acquisitions

0

Growth score

8

Mindshare score

-6

Scoring

Deals

$22.0M Private Equity

CNF Investments, New Science Ventures

Oct 31, 2013

$5.0M Debt

Jun 21, 2012

$18.8M Venture

Dec 1, 2011

$6.0M Debt

CNF Investments, Apjohn ventures

Nov 7, 2009

Employee Growth

Use Svelte Medical Systems's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Svelte Medical Systems's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

President and CEO
Vice President
Vice President
Vice President
Vice President

Similar Companies

Andes Biotechnologies

Andes Biotechnologies is a leading nucleic acid-based drug discovery and development company focused on solid tumor cancers.
Pre-Series A

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes